Total Revenue for Q1 2025
$61.3 million
Airway Clearance Revenue Increase
22%
2025 Revenue Guidance Range
$309 million to $315 million
Net Loss for Q1 2025
$3 million
Cash Position at End of Q1 2025
$83.6 million
Lymphedema Revenue for Q1 2025
$50.6 million
Lymphedema Revenue Decrease Percentage
3%
Key Facts
- Total Revenue for Tactile Systems Technology's Q1 2025 saw a modest 0.3% increase year over year, reaching $61.3 million.
- Airway Clearance Revenue experienced a significant 22% increase, reaching $10.7 million.
- 2025 Revenue Guidance has been revised to between $309 million and $315 million.
- Lymphedema Revenue faced a 3% decline, totaling $50.6 million.
- Net Loss increased by 35% to $3 million, or $0.13 per diluted share.
- The company's cash position at the end of the quarter stood at $83.6 million in cash and cash equivalents.